GSK anticipates to supply over 30 million doses of FLULAVAL, FLUARIX for 2010-2011 flu season
GlaxoSmithKline announced today that the U.S. Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) has released the first lots of FluLaval® [Influenza Virus Vaccine] allowing distribution in the U.S. to begin for the 2010-2011 flu season. GSK anticipates distribution of Fluarix® [Influenza Virus Vaccine] to follow in the next several weeks.

Ten steps to successful breastfeeding from WHO and UNICEF
During World Breastfeeding Week, celebrated from 1 to 7 August in more than 170 countries, WHO reiterates its call on health facilities and health workers to implement ten steps to help mothers breastfeed successfully and improve their babies' health and chances of survival.

THL signs definitive merger agreement to acquire Intermedix from Parthenon
Intermedix Corporation, a leading provider of revenue cycle management and software solutions to the emergency healthcare industry, announced today that Thomas H. Lee Partners, L.P. has signed a definitive merger agreement to acquire the Company from Parthenon Capital Partners and its minority shareholders.

FDA clears ZOLL's new Propaq MD Monitor/Defibrillator
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market and begin distribution of the new Propaq® MD Monitor/Defibrillator that was developed specifically to meet the special needs of military customers and air medical operations worldwide. Development of this product was a joint undertaking between the Department of Defense and a cooperative arrangement between Welch Allyn and ZOLL.

ZIOPHARM second-quarter net loss from operations increases to $5.1 million
ZIOPHARM Oncology, Inc., a biopharmaceutical cancer company addressing unmet medical needs, today reported its financial results for the three months ended June 30, 2010 and provided an update on the Company's continued progress with its clinical programs.

Paperwork for reimbursement prevents PCTs access to high-cost cancer drugs
The amount of paperwork that primary care trusts (PCTs) have to fill out in order to be reimbursed for cancer drugs is so great that they may be missing out on millions of pounds, a report suggests.

Vaccine scares may do more harm than previously believed to population's 'herd immunity'
Public immunization efforts may be much more sensitive than previously realized to small changes in the perceived costs or risks of vaccination, scientists at Harvard University report this week. In some cases, the spread of vaccine avoidance via social networks can make the difference between a minor, localized outbreak and an epidemic four times as large.

Opportunity in European embolization coil market leads to major acquisitions in 2010: MRG
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, high market opportunity in the European embolization coil market has led to several major acquisitions in 2010. The European market alone was valued at approximately $100 million in 2009, making successful niche competitors in this market attractive acquisition targets.

USIBC applauds Abbott for 100 years of improving healthcare in India
Today the U.S.-India Business Council (USIBC) saluted Abbott Laboratories for 100 years of improving healthcare in India. In 1910, Abbott was one of the first multinationals to establish operations in India. Over the past century, Abbott has been dedicated to connecting Indian patients with access to quality medication and patient care, enhancing the quality of life for its customers.

Endo Pharmaceuticals total revenues for second-quarter 2010 increase 6% to $396.5 million
Endo Pharmaceuticals today reported financial results for the second quarter 2010. Total revenues during the second quarter of 2010 increased 6 percent to $396.5 million, compared with $373.1 million in the same quarter of 2009. Net income for the three months ended June 30, 2010 was $51.5 million, compared with $30.0 million in the comparable 2009 period.

RSS integration by RSSinclude